Teva Pharmaceutical
TEVA
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 1 day ago • TEVA
3 Catalysts That Could Send Teva Stock to $40 and Beyond
GlobeNewsWire • 4 days ago • TEVA
Teva Launches Home Groundâ„¢ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners
GlobeNewsWire • 5 days ago • TEVA
Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics
Seeking Alpha • 5 days ago • TEVA
Teva: The Market Is Pricing The Past, Not The Pipeline - Initiating Buy
Zacks Investment Research • 18 days ago • TEVA
TEVA's Prolia Biosimilar Gets FDA Nod, Xolair Filing Accepted
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.